Where does Shire Human Genetic Therapies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shire Human Genetic Therapies, Inc. ranks #4,841 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Shire Human Genetic Therapies, Inc. hold?

Shire Human Genetic Therapies, Inc. holds 72 US utility patents granted between 2015 and 2025, spanning 24 technology areas.

What is Shire Human Genetic Therapies, Inc.'s Innovation Score?

Shire Human Genetic Therapies, Inc. has an Innovation Score of 45.0 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Shire Human Genetic Therapies, Inc.'s patent grant rate increasing or decreasing?

Shire Human Genetic Therapies, Inc.'s recent grant velocity is -49% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Shire Human Genetic Therapies, Inc.'s patents?

Shire Human Genetic Therapies, Inc.'s patents average 19.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Shire Human Genetic Therapies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Shire Human Genetic Therapies, Inc.

Q: What technology areas does Shire Human Genetic Therapies, Inc. focus on?

Shire Human Genetic Therapies, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 55 patents. Grants appear in 24 CPC subclasses total.

USPTO PatentsView assignee record - 72 granted patents across 24 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shire ranks #4,841 of 49,997 tracked US assignees by granted-patent volume, with 72 patents across 24 technology areas.

#4,841
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.0/100): 19.1
avg claims per patent: -49%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4841 · US Corporation #4,841 · 72 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 72 grants
TOP-DECILE #4,841/49,997
PHOTO-FINISH Saipem
CPC-FOCUS A61K · 24 areas
INNOV-PAR 45.0/100
CLAIMS-RICH 19.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -49% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Saipem S.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Alpha and Omega… · near

45
China Medical… · near

45
Provenance Asset Group · near

45
Schluter Systems · near

45
Shire Human Genetic… · this assignee

45
3D Lighting… · lowest

7

What this shows Shire's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Shire's grants concentrate

Shire Human Genetic Therapies, Inc. is a focused PatentsView assignee: 24 CPC subclasses with 76.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (15 grants) versus a trough of 1 in 2024. By volume, Shire sits between Saipem S.A. and Sirna Therapeutics, Inc..

Shire's three-year grant acceleration

From 2019–2021 to 2022–2024, Shire Human Genetic Therapies, Inc. moved from 24 to 5 grants (0.21x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Saipem

72
Samyang Holdings

72
Sealy Technology

72
Shenzhen Guanke

72
Shoei Chemical

72
SK Hynix Nand Pro…

72
Saluda Medical Pty

72
Sirna Therapeutics

72
Shire Human Genet… ◀

72

What this shows Shire holds 72 patents at rank #4,839, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shire

By rank, the assignees closest to #4,839 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Shire's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shire, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

China Medical University 45 Provenance Asset Group LLC 45 Schluter Systems L.P. 45 Alpha and Omega Semiconductor (Cayman) Ltd. 45

Similar claim depth

Nearest assignees by average claims per patent (19.1 here).

Alivecor, Inc. 19.1 avg The Administrators of the Tulane Educational Fund 19.1 avg Orion Labs, Inc. 19.1 avg Trimble Inc. 19.1 avg

Shire's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Shire Human Genetic Therapies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	12.5%
2016	11	15.3%
2017	15	20.8%
2018	7	9.7%
2019	5	6.9%
2020	13	18.1%
2021	6	8.3%
2022	4	5.6%
2024	1	1.4%
2025partial year	1	1.4%

Which technologies does Shire Human Genetic Therapies, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 55

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 50

C12Y - Enzymes 47

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 40

C07K - Peptides 27

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 7

C07D - Heterocyclic Compounds 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

Top 15 of 24 technology areas

Where it ranks

Overall rank by patents

#4,841

of 49,997 tracked assignees

Innovation Score

45.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Shire Human Genetic Therapies, Inc.'s patent record in context - here's where to go next.

Shire Human Genetic Therapies, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 76.4% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #4,841 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shire Human Genetic Therapies, Inc. against Saipem S.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.